Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine
✍ Scribed by Damiaan Denys; André A. Klompmakers; Herman G. M. Westenberg
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 190 KB
- Volume
- 176
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Rats received haloperidol (1.3-1.5 mg/kg/day) via their drinking water for 21 weeks. At the end of this period the density of D2 dopamine receptors and their affinity for [3H]-spiperone were measured in the striatum and medial prefrontal cortex. The chronic haloperidol treatment increased the densit
The noncompetitive NMDA receptor antagonist phencyclidine (PCP) and the neuronal cannabinoid receptor agonist ⌬ 9 -tetrahydrocannabinol (THC) are two agents shown to have psychotomimetic properties in humans. Both drugs increase dopamine release and utilization in the prefrontal cortex, a brain regi